Patient Perspectives in Mantle Cell Lymphoma Clinical Research

Clinical studies with a distinct emphasis on mantle cell lymphoma play a pivotal role in evaluating the safety and effectiveness of novel treatments for this disease. These trials are instrumental in ascertaining whether new medications surpass conventional therapies, providing substantial evidence to endorse their broad utilization. This particular study stands out as it centers on the firsthand experiences of individuals battling mantle cell lymphoma who are actively engaged in a clinical trial featuring medicinal interventions. The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this patient group.

NCT Number	NCT06049472
Lead Sponsor	Power Life Sciences Inc.
Conditions	Mantle Cell Lymphoma
Enrollment	500 participants
Start Date	2024-10
Primary Completion	2025-10 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2023-09-22